$CKX
CKX LANDS, INC.

2020 Q2 Form 10-Q Financial Statement

#000143774920016824 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q4 2019 Q2
Revenue $188.7K $212.7K $216.8K
YoY Change -12.97% 8.31% -44.98%
Cost Of Revenue $258.00 $15.86K $14.45K
YoY Change -98.21% 90.63% -63.88%
Gross Profit $188.4K $196.8K $202.4K
YoY Change -6.88% 4.66% -43.79%
Gross Profit Margin 99.86% 92.54% 93.34%
Selling, General & Admin $193.1K $147.3K $208.4K
YoY Change -7.36% -13.82% 60.33%
% of Gross Profit 102.47% 74.83% 103.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $234.00 $550.00 $504.00
YoY Change -53.57% -104.77% 115.38%
% of Gross Profit 0.12% 0.28% 0.25%
Operating Expenses $193.3K $147.5K $208.9K
YoY Change -7.47% -13.94% 60.72%
Operating Profit $204.1K $49.31K -$1.625K
YoY Change -12659.51% 196.16% -100.71%
Interest Expense $30.38K $25.06K $29.49K
YoY Change 3.02% -44.72% 194.9%
% of Operating Profit 14.89% 50.82%
Other Income/Expense, Net
YoY Change
Pretax Income $234.5K $74.37K $27.86K
YoY Change 741.55% 19.99% -88.43%
Income Tax $22.68K $11.40K $4.591K
% Of Pretax Income 9.67% 15.33% 16.48%
Net Earnings $211.8K $62.97K $23.27K
YoY Change 810.1% 55.1% -84.66%
Net Earnings / Revenue 112.24% 29.61% 10.73%
Basic Earnings Per Share $0.11 $0.01
Diluted Earnings Per Share $109.0K $32.42K $11.98K
COMMON SHARES
Basic Shares Outstanding 1.942M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q4 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.823M $6.478M $5.896M
YoY Change 15.71% 18.31% 100.56%
Cash & Equivalents $3.567M $3.280M $2.589M
Short-Term Investments $3.256M $3.198M $3.412M
Other Short-Term Assets $100.9K $39.73K $253.6K
YoY Change -60.22% 7.41% -74.12%
Inventory
Prepaid Expenses
Receivables $79.39K $102.8K $81.20K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.003M $6.620M $6.231M
YoY Change 12.39% 17.57% 55.15%
LONG-TERM ASSETS
Property, Plant & Equipment $9.241M $9.242M $9.234M
YoY Change 0.07% -0.04% 0.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $240.0K
YoY Change -100.0% -89.04%
Other Assets
YoY Change
Total Long-Term Assets $9.241M $9.242M $9.474M
YoY Change -2.47% -7.31% -16.92%
TOTAL ASSETS
Total Short-Term Assets $7.003M $6.620M $6.231M
Total Long-Term Assets $9.241M $9.242M $9.474M
Total Assets $16.24M $15.86M $15.71M
YoY Change 3.43% 1.67% 1.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.43K $62.25K $191.5K
YoY Change -58.0% -69.66% 36.79%
Accrued Expenses
YoY Change
Deferred Revenue $232.0K $165.2K
YoY Change 45.91%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $338.8K $227.4K $191.5K
YoY Change 76.9% 4.89% 18.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $338.8K $227.4K $191.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $526.5K $415.1K $379.2K
YoY Change 38.84% 2.62% 8.58%
SHAREHOLDERS EQUITY
Retained Earnings $15.66M $15.39M $15.27M
YoY Change 2.56% 1.65% 1.7%
Common Stock $59.34K $59.34K $59.34K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.72M $15.45M $15.33M
YoY Change
Total Liabilities & Shareholders Equity $16.24M $15.86M $15.71M
YoY Change 3.43% 1.67% 1.85%

Cashflow Statement

Concept 2020 Q2 2019 Q4 2019 Q2
OPERATING ACTIVITIES
Net Income $211.8K $62.97K $23.27K
YoY Change 810.1% 55.1% -84.66%
Depreciation, Depletion And Amortization $234.00 $550.00 $504.00
YoY Change -53.57% -104.77% 115.38%
Cash From Operating Activities $70.30K $119.4K -$11.25K
YoY Change -724.89% -16.78% -122.5%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.260K $0.00
YoY Change -73.57%
Acquisitions
YoY Change
Other Investing Activities $629.7K $224.8K $473.5K
YoY Change 32.99% -186.77% -164.86%
Cash From Investing Activities $629.7K $220.5K $473.5K
YoY Change 32.99% -180.13% -164.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 70.30K 119.4K -11.25K
Cash From Investing Activities 629.7K 220.5K 473.5K
Cash From Financing Activities 0.000 0.000
Net Change In Cash 700.0K 339.9K 462.2K
YoY Change 51.44% -358.05% -150.8%
FREE CASH FLOW
Cash From Operating Activities $70.30K $119.4K -$11.25K
Capital Expenditures $0.00 -$4.260K $0.00
Free Cash Flow $70.30K $123.7K -$11.25K
YoY Change -724.89% -22.51% -122.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 ckx Accrued Royalty Income
AccruedRoyaltyIncome
78753
CY2019Q4 ckx Accrued Royalty Income
AccruedRoyaltyIncome
84880
CY2020Q2 ckx Building And Equipment
BuildingAndEquipment
108602
CY2019Q4 ckx Building And Equipment
BuildingAndEquipment
108602
CY2020Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 ckx Certificates Of Deposit At Carrying Value Current And Noncurrent
CertificatesOfDepositAtCarryingValueCurrentAndNoncurrent
2753465
CY2019Q4 ckx Certificates Of Deposit At Carrying Value Current And Noncurrent
CertificatesOfDepositAtCarryingValueCurrentAndNoncurrent
2697000
CY2020Q2 ckx Certificates Of Deposit Maximum Value Per Deposit
CertificatesOfDepositMaximumValuePerDeposit
250000
CY2020Q2 ckx Deposit Assets Stumpage Agreements
DepositAssetsStumpageAgreements
137300
CY2019Q4 ckx Deposit Assets Stumpage Agreements
DepositAssetsStumpageAgreements
87300
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
17970
CY2020Q2 ckx Timber
Timber
2188409
CY2019Q4 ckx Timber
Timber
2188594
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
80426
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
62253
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
79394
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102786
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
26360
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78634
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78167
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q2 us-gaap Assets
Assets
16244083
CY2019Q4 us-gaap Assets
Assets
15862530
CY2020Q2 us-gaap Assets Current
AssetsCurrent
7003203
CY2019Q4 us-gaap Assets Current
AssetsCurrent
6620448
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
26815
CY2020Q2 us-gaap Cash
Cash
3567149
CY2019Q4 us-gaap Cash
Cash
3280289
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3280289
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1860736
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3567149
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2588785
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
286860
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
728049
CY2020Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2753465
CY2019Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2697000
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
59335
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
59335
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:justify;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:justify;">The Company maintains its cash balances in <div style="display: inline; font-style: italic; font: inherit;">seven</div> financial institutions. The amount on deposit in each financial institution is insured by the Federal Deposit Insurance Corporation up to <div style="display: inline; font-style: italic; font: inherit;">$250,000.</div></div></div></div></div>
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
232006
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
165158
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
-15395
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
218433
us-gaap Costs And Expenses
CostsAndExpenses
109041
us-gaap Costs And Expenses
CostsAndExpenses
282548
CY2020Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22683
CY2019Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4591
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
38131
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14754
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664
us-gaap Depletion
Depletion
184
us-gaap Depletion
Depletion
109
us-gaap Depreciation
Depreciation
467
us-gaap Depreciation
Depreciation
1011
CY2020Q2 us-gaap Depreciation
Depreciation
234
CY2019Q2 us-gaap Depreciation
Depreciation
504
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
502314
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
500642
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
308303
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
143746
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
253907
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
80876
CY2020Q2 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
220800
CY2019Q2 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
4950
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
253907
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
80876
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193087
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
208434
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
336209
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
328469
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
234473
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27862
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22683
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4591
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38131
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14754
us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
us-gaap Income Taxes Paid
IncomeTaxesPaid
67107
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
37758
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
74941
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
111381
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-25304
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
30381
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
29487
us-gaap Investment Income Interest
InvestmentIncomeInterest
48256
us-gaap Investment Income Interest
InvestmentIncomeInterest
56011
CY2020Q2 us-gaap Land
Land
7022503
CY2019Q4 us-gaap Land
Land
7023053
CY2020Q2 us-gaap Liabilities
Liabilities
526456
CY2019Q4 us-gaap Liabilities
Liabilities
415075
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16244083
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15862530
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
338792
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
227411
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
194818
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
779304
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
92042
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51255
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
211790
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
23271
us-gaap Net Income Loss
NetIncomeLoss
270172
us-gaap Net Income Loss
NetIncomeLoss
128992
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
211790
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23271
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
270172
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
128992
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
204092
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1625
us-gaap Operating Income Loss
OperatingIncomeLoss
260047
us-gaap Operating Income Loss
OperatingIncomeLoss
87735
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1985465
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
979000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3175
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2961
CY2019Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
100881
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39731
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1929000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1670000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
254458
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
109235
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9319514
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9320249
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9240880
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9242082
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15658292
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15388120
CY2020Q2 us-gaap Revenues
Revenues
188697
CY2019Q2 us-gaap Revenues
Revenues
216808
us-gaap Revenues
Revenues
369088
us-gaap Revenues
Revenues
370283
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15505837
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15717627
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
15303243
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15326514
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
15447455
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
15197522
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1503
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
246
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495

Files In Submission

Name View Source Status
0001437749-20-016824-index-headers.html Edgar Link pending
0001437749-20-016824-index.html Edgar Link pending
0001437749-20-016824.txt Edgar Link pending
0001437749-20-016824-xbrl.zip Edgar Link pending
ckx-20200630.xml Edgar Link completed
ckx-20200630.xsd Edgar Link pending
ckx-20200630_cal.xml Edgar Link unprocessable
ckx-20200630_def.xml Edgar Link unprocessable
ckx-20200630_lab.xml Edgar Link unprocessable
ckx-20200630_pre.xml Edgar Link unprocessable
ckx20200630_10q.htm Edgar Link pending
ex_196099.htm Edgar Link pending
ex_196100.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending